The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness
Open accessAbstract
In most carcinomas, invasion of malignant cells into surrounding tissues involves their molecular reprogramming as part of an epithelial-to-mesenchymal transition (EMT). Mutation of the APC gene in most colorectal carcinomas (CRCs) contributes to the nuclear translocation of the oncoprotein β-catenin that upon binding to T-cell and lymphoid enhancer (TCF-LEF) factors triggers an EMT and a proinvasive gene expression profile. A key inducer of EMT is the ZEB1 transcription factor whose expression promotes tumorigenesis and metastasis in carcinomas. As inhibitor of the epithelial phenotype, ZEB1 is never present in the epithelium of normal colon or the tumor center of CRCs where β-catenin remains membranous. We show here that ZEB1 is expressed by epithelial cells in intestinal tumors from human patients (familial adenomatous polyposis) and mouse models (APC Min/+ ) with germline mutations of APC that result in nuclear accumulation of β-catenin. However, ZEB1 is not expressed in the epithelium of hereditary forms of CRCs that carry wild-type APC and where β-catenin is excluded from the nucleus (Lynch syndrome). We found that β-catenin/TCF4 binds directly to the ZEB1 promoter and activates its transcription. Knockdown of β-catenin and TCF4 in APC -mutated CRC cells inhibited endogenous ZEB1, whereas forced translocation of β-catenin to the nucleus in APC -wild-type CRC cells induced de novo expression of ZEB1. Upregulation of MT1-MMP and LAMC2 by β-catenin/TCF4 has been linked to invasiveness in CRCs, and we show here that both proteins are activated by ZEB1 coexpressing with it in primary colorectal tumors with mutated APC . These results set ZEB1 as an effector of β-catenin/TCF4 signaling in EMT and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302 · cited 3×
“A key initial step in the EMT is the downregulation of E-cadherin, which at the transcriptional level is repressed by several factors; namely, ZEB1, ZEB2, SNAI1, SNAI2, Twist1, Twist2, and E12/E47 (1).”
BackgroundInfluentialMolecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., Knuechel, R., & Kirchner, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171610498 · Cited by 1,049
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5
Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K., & Quaranta, V. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.615 · Cited by 655
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 617
Sánchez-Tilló, E., Lázaro, A., Torrent, R., Cuatrecasas, M., Vaquero, E. C., Castells, A., Engel, P., & Postigo, A. (2010) · Oncogene · doi:10.1038/onc.2010.102 · Cited by 504
Self-citationSpaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
The APC tumour suppressor has a nuclear export function
Rosin-Arbesfeld, R., Townsley, F., & Bienz, M. (2000) · Nature · doi:10.1038/35023016 · Cited by 343 · cited 3×
“Using established cell lines of CRC with reportedly different levels of nuclear β-catenin (19), we found that endogenous β-catenin and TCF4 bind to the promoter region of ZEB1 and induces its expression.”
BackgroundMethodShirakihara, T., Saitoh, M., & Miyazono, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0249 · Cited by 320
Transactivation of Vimentin by Beta-Catenin in Human Breast Cancer Cells
Gilles, C., Polette, M., Mestdagt, M., Nawrocki-Raby, B., Ruggeri, P., Birembaut, P., & Foidart, J.-M. (2003) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200303001-00219 · Cited by 301
Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway
Postigo, A. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg225 · Cited by 294
Self-citationTargets of miR-200c mediate suppression of cell motility and anoikis resistance
Howe, E. N., Cochrane, D. R., & Richer, J. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2867 · Cited by 249
Expanding roles of ZEB factors in tumorigenesis and tumor progression.
Sànchez‐Tilló, E., Siles, L., de Barrios, O., Cuatrecasas, M., Vaquero, E. C., Castells, A., & Postigo, A. A. (2011) · Europe PMC (PubMed Central) · Cited by 203
Self-citationInomata, M., Ochiai, A., Akimoto, S., Kitano, S., & Hirohashi, S. (1996) · PubMed · Cited by 193
Hlubek, F., Jung, A., Kotzor, N., Kirchner, T., & Brabletz, T. (2001) · PubMed · Cited by 183
Nuclear export of the APC tumour suppressor controls β-catenin function in transcription
Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T., & Bienz, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg105 · Cited by 179
Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
Bottomly, D., Kyler, S. L., McWeeney, S. K., & Yochum, G. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq363 · Cited by 170
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Cochrane, D. R., Howe, E. N., Spoelstra, N. S., & Richer, J. K. (2010) · Journal of Oncology · doi:10.1155/2010/821717 · Cited by 162
Kobayashi, M., Honma, T., Matsuda, Y., Suzuki, Y., Narisawa, R., Asakura, H., & Ajioka, Y. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1112 · Cited by 151
Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer
Hlubek, F., Brabletz, T., Budczies, J., Pfeiffer, S., Jung, A., & Kirchner, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22916 · Cited by 151
Hlubek, F., Spaderna, S., Jung, A., Kirchner, T., & Brabletz, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11522 · Cited by 131
Pino, M. S., Kikuchi, H., Zeng, M., Herráiz, M., Sperduti, I., Berger, D. L., Park, D., Iafrate, A. J., Zukerberg, L. R., & Chung, D. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.12.010 · Cited by 118
Nuclear translocation of beta-catenin in hereditary and carcinogen- induced intestinal adenomas
Sheng, H., Shao, J., Williams, C. S., Pereira, M. A., Taketo, M. M., Oshima, M., Reynolds, A. B., Washington, M. K., DuBois, R. N., & Beauchamp, R. D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.4.543 · Cited by 96
Ip, Y. C., Cheung, S., & Fan, S. T. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20270 · Cited by 61
Cited by
The many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Dynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Sánchez-Tilló, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1122-2 · Cited by 518
Self-citationTargeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 412
Metadata
- Authors
- Sánchez-Tilló, E., de Barrios, O., Siles, L., Cuatrecasas, M., Castells, A., & Postigo, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-11-11
- Volume
- 108
- Issue
- 48
- Pages
- 19204-19209
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050089891
- Cited by
- 448
- References
- 30
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.